“BioShield” Law Nears Passage; FDA Proposes “Pre-Pre-IND” Meetings

FDA counterterrorism regulations will likely face added scrutiny following the expected enactment of Project BioShield, which allows for wider use of investigational products in emergency situations

More from Archive

More from Pink Sheet